Vnitr Lek 2008, 54(12):1127-1128

Ultrafiltrace a prevence alterace peritoneální membrány - determinanty úspěšnosti léčby peritoneální dialýzou - editorial

A. Paříková
Klinika nefrologie, Transplantační centrum IKEM Praha, přednosta doc. MUDr. Ondřej Viklický, CSc.

Received: October 16, 2008; Published: December 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Paříková A. Ultrafiltrace a prevence alterace peritoneální membrány - determinanty úspěšnosti léčby peritoneální dialýzou - editorial. Vnitr Lek. 2008;54(12):1127-1128.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rippe B, Venturoli D, Simonsen O et al. Fluid and electrolyte transport across the peritoneal membrane during CAPD according to the three-pore model. Perit Dial Int 2004; 24: 10-27. Go to original source... Go to PubMed...
    2. Krediet RT. Fluid absorption in the peritoneum - it is less simple than you thought. Nephrol Dial Transplant 1994; 9: 341-343.
    3. Coester AM, Parikova A, Smit W et al. Mechanisms in ultrafiltration failure of long-term peritoneal dialysis patients. Port J Nephrol Hypert 2008; 22: 217-220.
    4. Daugirdas JT, Ing TS, Gandhi VC et al. Kinetics of peritoneal fluid absorption in patients with chronic renal failure. J Lab Clin Med 1980; 95: 351-361.
    5. Struijk DG, Krediet RT, Imholz AL et al. Fluid kinetics in CAPD patients during dialysis with a bicarbonate-based hypoosmolar solution. Blood Purif 1996; 14: 217-226. Go to original source... Go to PubMed...
    6. Krediet RT, Struijk DG, Koomen GC et al. Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70. ASAIO Trans 1991; 37: 662-667. Go to PubMed...
    7. Smit W, van Dijk P, Langedijk MJ et al. Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 2003; 23: 440-449. Go to original source... Go to PubMed...
    8. Ho-Dac-Pannekeet MM, Schouten N, Langendijk MJ et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50: 979-986. Go to original source... Go to PubMed...
    9. Pecoits-Filho R, Mujais S, Lindholm B. Future of icodextrin as an osmotic agent in peritoneal dialysis. Kidney Int Suppl 2002; 81: S80-S87. Go to original source... Go to PubMed...
    10. Imholz AL, Brown CB, Koomen GC et al. The effect of glucose polymers on water removal and protein clearances during CAPD. Adv Perit Dial 1993; 9: 25-30. Go to PubMed...
    11. Tomo T. Peritoneal dialysis solutions low in glucose degradation products-evidence for clinical benefits. Perit Dial Int 2008; 28 (Suppl 3): S123-S127. Go to original source... Go to PubMed...
    12. Moberly JB, Mujais S, Gehr T et al. Pharmacokinetics of icodextrin in peritoneal dialysis patients. Kidney Int Suppl 2002; 81: S23-S33. Go to original source... Go to PubMed...
    13. Gokal R, Moberly J, Lindholm B et al. Metabolic and laboratory effects of icodextrin. Kidney Int Suppl 2002; 81: S62-S71. Go to original source... Go to PubMed...
    14. Mistry CD, Fox JE, Mallick NP et al. Circulating maltose and isomaltose in chronic renal failure. Kidney Int Suppl 1987; 22: S210-S214. Go to PubMed...
    15. Mistry CD, Gokal R. The use of glucose polymer (icodextrin) in peritoneal dialysis: an overview. Perit Dial Int 1994; 14 (Suppl 3): S158-S161. Go to original source... Go to PubMed...
    16. de Waart DR, Zweers MM, Struijk DG et al. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality. Perit Dial Int 2001; 21: 269-274. Go to original source... Go to PubMed...
    17. de Fijter CW, Verbrugh HA, Oe LP et al. Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid. Am J Kidney Dis 1993; 21: 411-418. Go to original source... Go to PubMed...
    18. Cooker LA, Choo CG, Luneburg P et al. Effect of icodextrin peritoneal dialysis solution on cell proliferation in vitro. Adv Perit Dial 1999; 15: 17-20. Go to PubMed...
    19. MacGinley R, Cooney K, Alexander G et al. Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution. Am J Kidney Dis 2002; 40: 1030-1035. Go to original source... Go to PubMed...
    20. Imholz AL, Brown CB, Koomen GC et al. The effect of glucose polymers on water removal and protein clearances during CAPD. Adv Perit Dial 1993; 9: 25-30. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.